GLENDA ENSWEILER: Open Payments
NPI 1891043212 · PLYMOUTH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 20 payments from 12 companies in 2025. Trend: 2023 $1,113 · 2024 $844 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $61 |
| Exact Sciences Corporation | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| PFIZER INC. | 2 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Viatris Specialty LLC | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: VRAYLAR, Cologuard Collection Kit, JARDIANCE, NURTEC ODT, TRINTELLIX, YUPELRI, Ozempic, Kerendia.
Industry payments across IN — which companies pay providers there.
